News

18.03.2022 (Обновлено: 30.03.2022 15:40)

The EEC has assessed the impact of draft decisions in the fields of veterinary measures, regulation of medicines and customs administration on businesses

The draft decisions of the Eurasian Economic Commission in the fields of veterinary measures, regulation of medicinal product circulation and customs administration have been reviewed at the meeting of the working group on regulatory impact assessment of the EEC draft decisions.

The meeting participants have reviewed the draft decisions of the EEC Board aimed to exclude excessive requirements for the importation and mutual movement of genetic material used for pedigree dog breeding. In particular, common veterinary requirements and veterinary certificate forms exclude provisions requiring to confirm welfare in terms of tuberculosis and the absence of pathogenic or toxicogenic microorganisms, as well as to carry out anthelminthic treatments.

The working group has supported the draft decision of the EEC Council on establishing common requirements for the evidence-based study of the safety and quality of plasma-derived medicinal products. The unification of these requirements within the Union will ensure the manufacturing of blood products with specified stable quality and safety parameters, as well as the management of risks associated with the safety of such medicinal products.

At the meeting, the members of the working group have agreed with the need to amend the customs value declaration form and rules for filling it out. These amendments aim to ensure that business entities have a clear understanding of the procedure for specifying in the customs value declaration of the information on the inclusion of license payments for using the objects of intellectual property in the customs value of goods